- Home
- OBIO vs BLNK Comparison
OBIO vs BLNK Comparison
Compare OBIO & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- BLNK
- Stock Information
- Founded
- OBIO 2017
- BLNK 2009
- Country
- OBIO United States
- BLNK United States
- Employees
- OBIO N/A
- BLNK N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- BLNK Industrial Specialties
- Sector
- OBIO Health Care
- BLNK Consumer Discretionary
- Exchange
- OBIO Nasdaq
- BLNK Nasdaq
- Market Cap
- OBIO 172.1M
- BLNK 129.3M
- IPO Year
- OBIO N/A
- BLNK N/A
- Fundamental
- Price
- OBIO $3.97
- BLNK $1.93
- Analyst Decision
- OBIO Strong Buy
- BLNK Buy
- Analyst Count
- OBIO 4
- BLNK 8
- Target Price
- OBIO $14.00
- BLNK $2.54
- AVG Volume (30 Days)
- OBIO 351.1K
- BLNK 7.1M
- Earning Date
- OBIO 11-11-2025
- BLNK 11-07-2025
- Dividend Yield
- OBIO N/A
- BLNK N/A
- EPS Growth
- OBIO N/A
- BLNK N/A
- EPS
- OBIO N/A
- BLNK N/A
- Revenue
- OBIO $2,944,000.00
- BLNK $104,788,000.00
- Revenue This Year
- OBIO $29.26
- BLNK N/A
- Revenue Next Year
- OBIO $10.65
- BLNK $19.30
- P/E Ratio
- OBIO N/A
- BLNK N/A
- Revenue Growth
- OBIO 41.61
- BLNK N/A
- 52 Week Low
- OBIO $2.20
- BLNK $0.63
- 52 Week High
- OBIO $6.50
- BLNK $2.65
- Technical
- Relative Strength Index (RSI)
- OBIO 67.94
- BLNK 53.20
- Support Level
- OBIO $3.53
- BLNK $1.69
- Resistance Level
- OBIO $3.80
- BLNK $1.93
- Average True Range (ATR)
- OBIO 0.34
- BLNK 0.20
- MACD
- OBIO 0.07
- BLNK -0.07
- Stochastic Oscillator
- OBIO 93.47
- BLNK 22.40
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.